lobbying_activities: 2817865
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2817865 | 576e40ee-3bb3-4f12-98d0-e210eff9714c | Q2 | BROYDRICK & ASSOCIATES | 7268 | TONIX PHARMACEUTICALS | 2022 | second_quarter | PHA | Funding new drug for PTSD and COVID 19. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2022-07-13T10:20:57-04:00 |